Cells,
Journal Year:
2021,
Volume and Issue:
10(7), P. 1639 - 1639
Published: June 30, 2021
Ischemic
stroke
is
the
second
cause
of
mortality
and
first
long-term
disability
constituting
a
serious
socioeconomic
burden
worldwide.
Approved
treatments
include
thrombectomy
rtPA
intravenous
administration,
which,
despite
their
efficacy
in
some
cases,
are
not
suitable
for
great
proportion
patients.
Glial
cell-related
therapies
progressively
overcoming
inefficient
neuron-centered
approaches
preclinical
phase.
Exploiting
ability
microglia
to
naturally
switch
between
detrimental
protective
phenotypes
represents
promising
therapeutic
treatment,
similar
way
what
happens
with
astrocytes.
However,
duality
present
many
roles
these
cells
upon
ischemia
poses
notorious
difficulty
disentangling
precise
pathways
target.
Still,
promoting
M2/A2
microglia/astrocyte
inhibiting
M1/A1
neurotoxic
profiles
globally
rendering
results
different
vivo
models
stroke.
On
other
hand,
described
oligodendrogenesis
after
brain
seems
be
strictly
beneficial,
although
less
studied
players
paradigm
negative
effects
could
oligodendrocytes
next
years.
Here,
we
review
recent
advances
understanding
role
mentioned
glial
cell
types
main
pathological
events
ischemic
stroke,
including
inflammation,
blood
barrier
integrity,
excitotoxicity,
reactive
oxygen
species
management,
metabolic
support,
neurogenesis,
among
others,
special
attention
tested
approaches.
Frontiers in Neurology,
Journal Year:
2020,
Volume and Issue:
11
Published: Dec. 9, 2020
The
blood-brain
barrier
(BBB)
is
a
dynamic
interface
responsible
for
maintaining
the
central
nervous
system
homeostasis.
Its
unique
characteristics
allow
protecting
brain
from
unwanted
compounds,
but
its
impairment
involved
in
vast
number
of
pathological
conditions.
Disruption
BBB
and
increase
permeability
are
key
development
several
neurological
diseases
have
been
extensively
studied
stroke.
Ischemic
stroke
most
prevalent
type
characterized
by
myriad
events
triggered
an
arterial
occlusion
that
can
eventually
lead
to
fatal
outcomes
such
as
hemorrhagic
transformation
(HT).
seems
follow
multiphasic
pattern
throughout
different
stages
associated
with
distinct
biological
substrates.
In
hyperacute
stage,
sudden
hypoxia
damages
BBB,
leading
cytotoxic
edema
increased
permeability;
acute
neuroinflammatory
response
aggravates
injury,
higher
consequent
risk
HT
be
motivated
reperfusion
therapy;
subacute
stage
(1-3
weeks),
repair
mechanisms
take
place,
especially
neoangiogenesis.
Immature
vessels
show
leaky
this
has
improved
clinical
recovery.
chronic
(>6
restoration
factors
leads
start
decreasing
permeability.
Nonetheless,
will
persist
some
degree
weeks
after
injury.
Understanding
behind
dysregulation
pathophysiology
could
potentially
help
guide
care
decisions
new
therapeutic
targets;
however,
effective
translation
into
practice
still
lacking.
review,
we
address
physiological
through
ischemic
their
role
Biomedicine & Pharmacotherapy,
Journal Year:
2022,
Volume and Issue:
148, P. 112719 - 112719
Published: Feb. 12, 2022
Neuroprotective
and
neurorestorative
therapy
represent
two
major
drug
intervention
strategies
for
ischemic
stroke.
Multiple
factors
such
as
excitotoxicity,
inflammation,
angiogenesis,
neurogenesis
are
the
main
pathological
processes
that
underlie
acute
chronic
brain
injury.
Furthermore,
their
intimate
interactions
mediate
blood-brain
barrier
permeability,
increase
neurovascular
unit
structural
damage
well
a
hemorrhagic
transformation
during
We
aimed
to
review
current
understandings
of
underlying
mechanisms
neuroprotection
neurorestoration
in
Notably,
traditional
Chinese
medicine
(TCM)
has
notable
advantages
comprehensive
treatment
overall
regulation
multi-site
multi-target
diseases.
Therefore,
we
reviewed
recent
advances
natural
compounds
from
medicinal
herbs
possess
bioactivities
simultaneously
promoting
(e.g.,
oxidative
stress,
apoptosis,
autophagy)
neurogenesis,
axonal
sprouting)
following
ischemia
These
were
divided
into
glycosides
(astragaloside
IV,
gastrodin,
ginsenoside
Rg1
salidroside),
flavonoids
(baicalin,
icariin,
puerarin
breviscapine),
phenols
(resveratrol,
curcumin
salvianolic
acid
B),
terpenes
(ginkgolide
B
catalpol).
found
all
exhibited
anti-brain
activities
vivo
vitro
experiments
by
and,
or
neurorestoration.
This
tracks
summarizes
progress
past
five
years
explore
active
molecular
TCMs
produce
pro-neuroprotection
pro-neurorestoration.
Additionally,
provide
another
basis
reference
supporting
TCMs,
which
could
ultimately
lead
development
precise
clinical
medications
stroke
treatment.
Glia,
Journal Year:
2019,
Volume and Issue:
68(5), P. 1031 - 1045
Published: Dec. 3, 2019
Abstract
Microglia
constantly
survey
the
brain
microenvironment
and
rapidly
adopt
different
phenotypes
in
response
to
environmental
stimuli.
Such
dynamic
functions
require
a
unique
metabolism
bioenergetics.
However,
little
is
known
about
basic
of
microglia
how
metabolic
changes
regulate
function.
Here,
we
uncover
that
activation
accompanied
by
extensive
transcriptional
glucose
lipid
metabolism‐related
genes.
Using
flux
assays,
found
LPS,
prototype
pathogen‐associated
molecular
patterns
(PAMPs),
significantly
enhanced
glycolysis
but
suppressed
oxidative
phosphorylation
(OXPHOS)
primary
cultured
microglia.
By
contrast,
ATP,
damage‐associated
pattern
(DAMPs)
triggers
sterile
microglia,
boosted
both
OXPHOS.
Importantly,
LPS
ATP
activated
mechanistic
target
rapamycin
(mTOR)
pathway
intracellular
reactive
oxygen
species
(ROS).
Inhibition
mTOR
activity
ROS
production
conditions
exerted
effects
on
OXPHOS:
it
attenuated
ATP‐induced
elevation
OXPHOS,
yet
had
no
impact
LPS‐induced
suppression
Further,
inhibition
or
decreased
proinflammatory
cytokines
tumor
necrosis
factor‐α
(TNF‐α)
derived
neurotrophic
factor
(BDNF)
Our
study
reveals
critical
role
for
regulation
programming
shape
their
distinct
under
states
shed
light
potential
application
targeting
interfere
with
microglia‐mediated
neuroinflammation
multiple
disorders.
Neuroscience Bulletin,
Journal Year:
2022,
Volume and Issue:
38(10), P. 1229 - 1247
Published: May 5, 2022
Abstract
Ischemic
stroke
caused
by
intracranial
vascular
occlusion
has
become
increasingly
prevalent
with
considerable
mortality
and
disability,
which
gravely
burdens
the
global
economy.
Current
relatively
effective
clinical
treatments
are
limited
to
intravenous
alteplase
thrombectomy.
Even
so,
patients
still
benefit
little
due
short
therapeutic
window
risk
of
ischemia/reperfusion
injury.
It
is
therefore
urgent
figure
out
neuronal
death
mechanisms
following
ischemic
in
order
develop
new
neuroprotective
strategies.
Regarding
pathogenesis,
multiple
pathological
events
trigger
activation
cell
pathways.
Particular
attention
should
be
devoted
excitotoxicity,
oxidative
stress,
inflammatory
responses.
Thus,
this
article,
we
first
review
principal
underlying
mediated
these
significant
events,
such
as
intrinsic
extrinsic
apoptosis,
ferroptosis,
parthanatos,
pyroptosis,
necroptosis,
autophagic
death.
Then,
further
discuss
possibility
interventions
targeting
summarize
present
pharmacological
achievements.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(8), P. 4280 - 4280
Published: April 20, 2021
Transient
or
permanent
loss
of
tissue
perfusion
due
to
ischaemic
stroke
can
lead
damage
the
neurovasculature,
and
disrupt
brain
homeostasis,
causing
long-term
motor
cognitive
deficits.
Despite
promising
pre-clinical
studies,
clinically
approved
neuroprotective
therapies
are
lacking.
Most
studies
have
focused
on
neurons
while
ignoring
important
roles
other
cells
neurovascular
unit,
such
as
astrocytes
pericytes.
Astrocytes
for
development
maintenance
blood–brain
barrier,
structural
support,
control
cerebral
blood
flow
secretion
factors.
Emerging
data
suggest
that
astrocyte
activation
exerts
both
beneficial
detrimental
effects
following
stroke.
Activated
provide
neuroprotection
contribute
neurorestoration,
but
also
secrete
inflammatory
modulators,
leading
aggravation
lesion.
more
resistant
than
cell
types
pathology,
exert
a
regulative
effect
in
response
ischaemia.
These
remain
incompletely
understood,
though
they
represent
an
appealing
target
protection
In
this
review,
we
summarise
astrocytic
contributions
repair
stroke,
explore
mechanisms
promote
revascularisation
which
may
be
targeted
developing
novel
Neurobiology of Disease,
Journal Year:
2021,
Volume and Issue:
152, P. 105290 - 105290
Published: Feb. 6, 2021
In
response
to
various
types
of
environmental
and
cellular
stress,
microglia
rapidly
activate
exhibit
either
pro-
or
anti-inflammatory
phenotypes
maintain
tissue
homeostasis.
Activation
can
result
in
changes
morphology,
phagocytosis
capacity,
secretion
cytokines.
Furthermore,
microglial
activation
also
induces
energy
demand,
which
is
dependent
on
the
metabolism
metabolic
substrates
including
glucose,
fatty
acids,
amino
acids.
Accumulating
evidence
demonstrates
reprogramming
acts
as
a
key
driver
immune
response.
For
instance,
pro-inflammatory
states
preferentially
use
glycolysis
for
production,
whereas,
cells
are
mainly
powered
by
oxidative
phosphorylation
acid
oxidation.
this
review,
we
summarize
recent
findings
regarding
pathways
under
physiological
pathological
circumtances.
We
will
then
discuss
how
orchestrate
variety
central
nervous
system
pathologies.
Finally,
highlight
manipulating
reprogram
towards
beneficial
functions,
illustrate
therapeutic
potential
inflammation-related
neurological
diseases.
CNS Neuroscience & Therapeutics,
Journal Year:
2021,
Volume and Issue:
27(5), P. 515 - 527
Published: March 1, 2021
Abstract
Stroke
is
a
leading
cause
of
disability
and
mortality,
with
limited
treatment
options.
After
stroke
injury,
microglia
CNS‐resident
macrophages
are
rapidly
activated
regulate
neuropathological
processes
to
steer
the
course
functional
recovery.
To
accelerate
this
recovery,
can
engulf
dying
cells
clear
irreparably‐damaged
tissues,
thereby
creating
microenvironment
that
more
suitable
for
formation
new
neural
circuitry.
In
addition,
monocyte‐derived
cross
compromised
blood‐brain
barrier
infiltrate
injured
brain.
The
specific
functions
myeloid
lineage
in
brain
injury
repair
diverse
dependent
on
phenotypic
polarization
statuses.
However,
it
remains
be
determined
what
degree
CNS‐invading
occupy
different
niches
from
microglia.
review,
we
describe
physiological
characteristics
developing
adult
We
also
review
(a)
activation
after
stroke,
(b)
molecular
mechanisms
control
status,
(c)
contribution
pathology
versus
repair.
Finally,
summarize
current
breakthroughs
therapeutic
strategies
calibrate
microglia/macrophage
responses
stroke.
CNS Neuroscience & Therapeutics,
Journal Year:
2022,
Volume and Issue:
28(9), P. 1279 - 1293
Published: June 25, 2022
Phagocytosis
is
the
cellular
digestion
of
extracellular
particles,
such
as
pathogens
and
dying
cells,
a
key
element
in
evolution
central
nervous
system
(CNS)
disorders.
Microglia
macrophages
are
professional
phagocytes
CNS.
By
clearing
toxic
debris
reshaping
matrix,
microglia/macrophages
help
pilot
brain
repair
functional
recovery
process.
However,
CNS
resident
invading
immune
cells
can
also
magnify
tissue
damage
by
igniting
runaway
inflammation
phagocytosing
stressed-but
viable-neurons.